RecruitingNCT05185492

Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock


Sponsor

STAVROS G DRAKOS

Enrollment

500 participants

Start Date

May 25, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Primary diagnosis of cardiogenic shock at time of index evaluation; including acute myocardial infarction- and acute decompensated heart failure-cardiogenic shock phenotypes
  • Patients with cardiac arrest complicating cardiogenic shock and those with massive pulmonary embolism with right ventricular cardiogenic shock will also be eligible for the registry

Exclusion Criteria1

  • Patients with shock not due to primary cardiac etiology will be excluded. These include septic, hemorrhagic, and anaphylactic shock.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Cleveland Clinic Florida

Weston, Florida, United States

Inova Heart and Vascular Institute

Falls Church, Virginia, United States

University of Toronto

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05185492


Related Trials